top of page

SDG Newsletter - Goal 3: Good Health and Well-being

Updated: Apr 29, 2023

October 10, 2022



Registration Open: Journals of Justice x Project Seventeen EPA Workshop


Join the Journals of Justice and Project Seventeen's workshop focusing on the work of different Environmental Protection Agencies (EPAs). Build communication and respectful listening skills, and meet and discuss with people from all over the world!

Date: October 15th, 2022 (US)

Time: 6PM PST or 9AM Beijing Time

 

Goal 3 | Department of Economic and Social Affairs SDG 3 highlights the importance of health and well being in global populations, including improved physical and mental health outcomes worldwide, universal access to healthcare, and the development of health infrastructure in developing countries. Notably, COVID-19 has gravely disrupted decades of progress in global health, infecting more than 500 million people and killing more than 6.2 million worldwide. Not only has the pandemic disrupted essential health services worldwide, but also it has exacerbated inequities in access to health services (between countries and individuals), and shortened life expectancy.

WHO: COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide According to the World Health Organization (WHO), the global prevalence of depression and anxiety has increased by 25%. This is due to multiple factors, such as loneliness and social isolation caused by quarantine, constraints on people’s daily lives, fear of infection, and the death of loved ones - all leading up to a cynical view of the world during the pandemic. Not only is the population being hit hard, both mentally and socially, but this prevalence of the mental disorders has also revealed a serious gap in mental health services and a lack of funding. The problem is serious, demanding urgent psychosocial support from countries across the globe. Indeed, this shall be seen as a wake-up call for all countries to unite and work together, to provide professional mental support (via online or in-person) for not one but all.


Monkeypox Shots, Treatments and Tests Are Unavailable in Much of the World | The New York Times Countries such as Peru, containing the largest amount of monkey-pox cases, are receiving little to no vaccines as all treatment is centered in the US and Europe. The United States has placed a monopoly on smallpox vaccines and prohibits less wealthy countries from accessing these resources, leaving them to suffer the consequences of the health emergency. In addition, there is limited data to the number of daily monkeypox cases because countries such as Africa do not have access to tests. High income countries have gathered these smallpox vaccines and refused to distribute them globally, neglecting the most important step to overcoming this crisis. There is a negative lethargic response to this crisis where there is no concern due to the high mortality rate, causing countless to ignore the risky behavior of this new virus.

 

Further Reading

 

Want to learn more? Join us for a discussion to collaborate with students across the world, engage in new perspectives on the 17 Sustainable Development Goals, and connect with UNA-USA officials and members throughout the country. 

7 views0 comments

Recent Posts

See All

Comments


bottom of page